Associated Papers
dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Study.
Xiong J et al.
Medicine, 2016
Acquisition of chemoresistance to gemcitabine is induced by a loss-of-function missense mutation of DCK.
Nakano T et al.
Biochemical and Biophysical Research Communications, 2015
Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia.
Gabor KM et al.
Pediatric Blood & Cancer, 2015
Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
Baker JA et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2013
The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma.
Erčulj N et al.
Pharmacogenetics and Genomics, 2012
Pharmacogenetics and pharmacoepigenetics of gemcitabine.
Candelaria M et al.
Medical Oncology (northwood, London, England), 2010
Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.
Kocabas NA et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2008
Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
Lamba JK et al.
The Journal of Pharmacology and Experimental Therapeutics, 2007
Select a paper to view details